https://www.selleckchem.com/products/1-nm-pp1.html
This information supports the use of embryo-fetal toxicity data in KO models as part of weight of evidence approaches in the communication of developmental toxicity risk of pharmaceutical compounds.Stimulants are the first-line medication for attention-deficit/hyperactivity disorder (ADHD), and methylphenidate (MPH) is the first choice in Europe, with good efficacy and acceptable tolerability in a short-term course during childhood and adolescence.1 ADHD is, however a chronic condition, and patients can receive pharmacological treatmen